| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | -0.0095 | 0.8 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.009 | 0.8 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.0078 | 0.8 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | -0.0094 | 0.8 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | -0.0083 | 0.8 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.0081 | 0.8 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | -0.0094 | 0.8 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | -0.0088 | 0.8 |